Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Vietnam’s New AI Robot Cuts Bone to Millimetre Accuracy While the Surgeon Watches
Tam Anh General Hospital in Ho Chi Minh City has become Vietnam's first site to use the CUVIS‑Joint AI surgical robot, making the country the ninth worldwide to deploy the fully autonomous knee and hip replacement system. Developed by South Korean firm CUREXO and FDA‑cleared, the robot plans, cuts and stops independently, achieving millimetre precision. It accurately predicts tibial implant size 100% of the time and femoral size 98.9%, reducing complications. The first patient, a 74‑year‑old woman, walked unaided the day after surgery, underscoring rapid recovery potential.
Amazon Teams Up with Berry Street to Expand Access to Nutrition Therapy
Amazon has incorporated nutrition‑therapy platform Berry Street into its Health Benefits Connector, a marketplace that links employees with employer‑covered digital health services. When shoppers look for nutrition products, the connector promotes Berry Street’s virtual dietitian network of about 1,500 clinicians covering weight...
Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. Difficile Infection Will Continue...
Vedanta Biosciences announced that the independent Data Monitoring Committee has completed the first prespecified interim analysis of its Phase 3 RESTORATiVE303 trial and recommended the study continue unchanged. The interim data showed efficacy surpassing the futility threshold with no new safety...
Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
Pulse Biosciences (Nasdaq: PLSE) will present at the 25th Annual Needham Virtual Healthcare Conference on April 16, 2026, at 9:30 am ET. The company will showcase its proprietary nPulse™ platform, which uses nanosecond pulsed field ablation (nsPFA™) to treat atrial fibrillation and...
Reforming Public Health in India: A Roadmap to Universal Health Coverage
India’s public health system, despite its nationwide reach, still fails to provide free, high-quality universal health coverage. The Lancet Commission on a Citizen‑Centred Health System for India, launched in 2020, outlines six reform actions to transform the public sector, emphasizing...
CDC Releases Report on Flu, COVID-19 Vaccination Coverage for Health Care Workers for 2024-25 Respiratory Season
The CDC released its 2024‑25 respiratory‑season report showing that 76.3% of health‑care workers received flu shots and 40.2% were vaccinated against COVID‑19. Coverage rose when employers provided on‑site vaccinations, reaching 73% for flu and 42.9% for COVID‑19, versus 41.4% and...
FAQ Addresses Enforcement Discretion for Plan Compliance Under Certain No Surprises Act Provisions
The Centers for Medicare & Medicaid Services, together with Labor, Treasury and OPM, issued a joint FAQ on April 1 confirming that they will keep using enforcement discretion for No Surprises Act compliance when plans calculate qualifying payment amounts (QPAs) with...
New Study Links Obstructive Sleep Apnea to Increased Risk of Mortality and Cardiovascular Events
A new retrospective study presented at ECO 2026 examined 20,300 adults with obstructive sleep apnea (OSA) against 97,412 matched controls in North‑West London. Over up to four years of follow‑up, OSA patients experienced a 71% higher risk of cardiovascular events or...
CMS Seeks Applicants for LEAD ACO Model
The Centers for Medicare & Medicaid Services (CMS) announced a call for applications to its new LEAD ACO Model, an innovative Medicaid‑focused accountable care organization initiative. The model, launched by the CMS Innovation Center, targets improvements in care coordination for...
![[Comment] Targeted Advertising in Generative Artificial Intelligence Chatbots: A New Public Health Risk](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/26ba616f3e3f2861b999eb892835dbac.webp)
[Comment] Targeted Advertising in Generative Artificial Intelligence Chatbots: A New Public Health Risk
OpenAI announced it will embed targeted advertising in the free and low‑cost versions of ChatGPT, pairing the rollout with safeguards such as ad‑response separation, privacy protections, age gating for users under 18, and limits on health‑related ads. The move addresses...
![[Comment] Rethinking Country Classifications Towards a More Equitable Global Health Future](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/4b3ad670d67640fd05398f327e60ff90.webp)
[Comment] Rethinking Country Classifications Towards a More Equitable Global Health Future
The authors argue that the World Bank’s income‑based country classification, which groups nations into low, middle and high income based on gross national income per capita, no longer reflects health system realities. They show that income alone masks profound heterogeneity...
Cut Medicaid Fraud, Not Add Wealth Tax
The expressed rationale for SEIU's proposed wealth tax is to replace the roughly $20b / yr in Medicaid $$ the federal govt recently stripped from CA. Maybe instead of enacting yet another tax, which is already driving our ~most productive residents...
Large-Scale Study Links Autoimmune Diseases to Higher Rates of Depression and Anxiety
Researchers analyzing data from 1.5 million UK adults found that individuals with autoimmune diseases are almost twice as likely to have been diagnosed with depression, anxiety or bipolar disorder compared with the general population. After adjusting for pain, social isolation and...
![[UPDATED] CMS Proposes 2.4% Hospice Rate Increase for 2027](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hospicenews.com/wp-content/uploads/sites/6/2023/02/washington-monument-1628558_1280.jpg)
[UPDATED] CMS Proposes 2.4% Hospice Rate Increase for 2027
The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% payment increase for hospice providers in fiscal year 2027, translating to roughly $785 million in additional funding. The hospice per‑patient cap would rise to $36,210.11, up from $35,361.44...
The Most Common Age Perimenopause Starts, & What You Can Do To Prepare
Perimenopause, the hormonal transition before menopause, typically starts in a woman's 40s and can span seven to ten years. Symptoms are diverse—insomnia, fatigue, mood swings, hot flashes, and more—affecting daily life and often mistaken for other conditions. Awareness remains low;...
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory
The Nasdaq’s recent dip into correction territory has renewed focus on defensive, dividend‑paying healthcare stocks. Analysts highlight AbbVie and Amgen as attractive options, citing strong product pipelines, robust margins, and yields above 2.7%. AbbVie’s immunology drugs Skyrizi and Rinvoq are...
Impactful Innovations Reshape Learning and Technology at ACC 2026
The American College of Cardiology’s 2026 meeting highlighted AI’s transition from hype to a practical clinical tool, showcasing nearly 200 FDA‑cleared cardiology algorithms and embedding AI into the conference app. Attendees experienced live, mobile CCTA scans with AI‑driven plaque analysis,...
Biotech Innovation Makes Inroads Against Bleeding Disorders
Biotech breakthroughs have transformed bleeding disorders from fatal diagnoses into manageable chronic conditions, with extended‑half‑life clotting factors, subcutaneous non‑factor drugs, and emerging gene therapies extending dosing intervals to weeks or months. The National Bleeding Disorders Foundation’s Pathway to Cures fund...
Why Leaving Hospital Medicine for Private Practice Was Worth the Risk
Dr. Shiv K. Goel left his role as medical director at a San Antonio hospital to launch Prime Vitality, a functional, integrative practice. He faced steep financial pressures, overhead worries, and professional isolation during the first year. A breakthrough patient...
When Snoring Is a Signal of Health Risks
Snoring, often dismissed as a harmless nuisance, can be a warning sign of obstructive sleep apnea (OSA), a condition where the airway collapses repeatedly during sleep. Persistent, loud snoring is linked to reduced oxygen levels, triggering stress hormones and elevating...
News 4/3/26
The article forecasts that the Chief Health AI Transformation Officer (CHAITO) role will be downgraded to a director position before being eliminated entirely, with its duties folded into the chief information officer’s portfolio. This shift reflects growing skepticism about proliferating...
Boston University to Apply Machine Learning to Alzheimer’s Biomarker and Cognitive Data
Boston University, leading the AI for Alzheimer’s Disease (AI4AD) consortium, is coordinating 11 research institutes to apply machine learning to massive genomic, biomarker and cognitive datasets. The team is building the PreSiBO database, which tags predictor, signature, biomarker and outcome...
Trump's Obesity Drug Plan for Medicare Would Cost Insurers Billions
President Donald Trump’s proposal to add GLP‑1 obesity drugs to Medicare would impose billions of dollars in costs on private insurers during the first year. The administration claims negotiated drug‑price cuts will offset expenses, but a Vanderbilt‑led analysis estimates only...
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
President Trump has announced 100% tariffs on patented pharmaceutical products that lack a Most‑Favored Nation (MFN) agreement with his administration. The tariffs will take effect in 120 days for large firms and 180 days for smaller ones, while imports from...
Association Between PNI and All-Cause Mortality in Ischemic Stroke Patients: A Large-Scale Retrospective Cohort Study
A retrospective cohort of 1,152 ischemic stroke patients in China found the prognostic nutritional index (PNI) to be a strong, independent predictor of all‑cause mortality. Over a median 14.2‑month follow‑up, 96 deaths occurred, and each one‑point rise in PNI lowered...
Ottawa Allocates $15 Million to Build Two Mental‑Health Treatment Centres for First‑Responders
Ottawa announced a $15 million federal contribution to construct two new mental‑health facilities for first‑responders in the Greater Toronto Area – an outpatient clinic in Toronto and a residential recovery centre in Caledon. The sites, to be run by Runnymede Healthcare...
What the Leaked Claude Code Codebase Tells Healthcare Builders About Designing Agentic Health Tech
On March 31, 2026 a 59.8 MB source‑map file unintentionally exposed Anthropic’s Claude Code TypeScript codebase, revealing roughly 512,000 lines of production‑grade AI agent logic. The leak showcases a three‑layer skeptical memory system, a coordinator mode for multi‑agent orchestration, the AutoDream consolidation...
There’s an Estrogen Patch Shortage. Here’s What to Do If You’re Affected
A nationwide shortage of estrogen patches is leaving many U.S. women without a key menopause treatment. Prescriptions for hormone replacement therapy have surged 86% since 2021, spurred by the FDA’s removal of a black‑box warning in November. The patch’s popularity...
Pharmaceutical Giant Pfizer Forced To Shut Down Updated COVID Vaccine Trials
Pfizer announced it is halting development of its updated COVID‑19 vaccine candidates, ending ongoing Phase 2/3 trials that targeted newer variants. The decision follows mixed efficacy data and waning commercial demand as the pandemic recedes. Pfizer will redirect resources toward...
FDA Clears Eli Lilly’s Once‑Daily GLP‑1 Pill Foundayo, Expanding Oral Obesity Options
The U.S. Food and Drug Administration approved Eli Lilly’s oral GLP‑1 obesity medication Foundayo on April 1, 2026. The once‑daily pill can be taken any time of day without food or water restrictions and is priced between $149 and $349 a month,...
Bodycote Plans to Open a New Heat Treatment Facility in Mexico
Bodycote, the London‑based heat‑treatment specialist, will open a new facility in Apodaca near Monterrey, Mexico, slated to start operations in 2026. The plant expands capacity for case hardening, nitriding, carburizing, carbonitriding and nitrocarburizing, targeting medical, automotive and general industrial customers....
Underfunded Data Infrastructure Undermines Public Health Systems
A recent essay adapted from Nonprofit Quarterly warns that chronic underinvestment in information infrastructure is jeopardizing public health and the effectiveness of health‑tech solutions. The piece argues that donors often overlook the shared, reliable data environment that underpins disease surveillance,...
Changemaker Spearheads Ohio's AI Center of Excellence
John Paganini, president of Paguar Informatics and former HIMSS employee, spearheaded the creation of the Northern Ohio HIMSS chapter’s AI Center of Excellence. The new hub now counts 140 members ranging from clinicians to IT leaders. Its mission is to...
Bipartisan INSULIN Act Targets $35 Monthly Cap for Private‑Insurance Users
A coalition of Democratic and Republican senators has introduced the INSULIN Act, aiming to cap insulin prices at $35 per month for people with private insurance. The bill also proposes a pilot program for uninsured patients in ten states, sparking...
Postdoc Position: Model Environmental & Biological Impacts on Cognition
🚨 Hiring Postdoctoral researcher cognitive development Radboud University Medical Center (Radboudumc) Job descriptionWe are looking for a postdoctoral scientist to model the relationship between environmental and biological factors on cognitive development. 📩
Lipocine Shares Plunge 78% After Phase 3 Oral Brexanolone Trial Misses Primary Endpoint
Lipocine Inc.'s stock fell 78% to $2.00 after its Phase 3 placebo‑controlled trial of oral brexanolone (LPCN 1154) missed the primary efficacy endpoint for postpartum depression. The company said it will preserve capital and engage stakeholders to evaluate next steps, underscoring...
Mount Sinai OB-GYN Groups Relocate to 7K SF at 348 Amsterdam Avenue
Mount Sinai’s two OB‑GYN faculty practice groups are moving to a 7,000‑sq‑ft medical office at 348 Amsterdam Avenue on the Upper West Side. The space, formerly a Modell’s sporting‑goods store, is being gutted and will reopen in June with obstetrics,...
Smoked Cannabis Reduces Immediate Alcohol Consumption in Controlled Laboratory Trial
A double‑blind crossover trial with 157 heavy drinkers found that smoking cannabis before alcohol reduced immediate consumption. A moderate THC dose (3.1%) cut intake by 19%, while a higher dose (7.2%) lowered it by 27% compared with placebo. The high‑THC...
Cost-Related Medication Non-Adherence Declined After the Inflation Reduction Act
The Inflation Reduction Act provisions that took effect Jan. 1, 2024, capping out‑of‑pocket drug costs for Medicare beneficiaries, have led to measurable improvements in medication adherence. A NIH‑funded analysis of the National Health Interview Survey compared 2024 responses with 2021‑2023 data and...
Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD
The SirPAD trial showed that a sirolimus‑coated drug‑coated balloon (MagicTouch) significantly lowered major adverse limb events (MALE) to 8.8% versus 15% with uncoated balloons in femoropopliteal and below‑the‑knee peripheral artery disease patients. At one year, the composite of unplanned amputation...
Pharma and Biotech Layoffs 2026 Watch
Pharma and biotech companies continued extensive workforce reductions in early 2026, with Takeda alone eliminating 634 U.S. positions as part of a $1.2 billion annual savings plan, while Amgen, GSK, and Merck KGaA also announced cuts ranging from dozens to several...
Inside The New Rules Of Home-Based Care Dealmaking
Home‑based care M&A is moving away from the old playbook of rapid, scale‑driven deals toward a more disciplined, data‑rich approach. Buyers now scrutinize billable hours, caregiver KPIs, payer mix and AI technology stacks, while cultural compatibility has become a decisive...
Blocking KDM4 Reactivates Tumor Suppressor, Halts AML
Scientists have restored a silenced tumor-suppressor gene in mice with acute myeloid leukemia by blocking KDM4 enzymes, suggesting a potential new therapeutic approach that avoids harming normal blood cells. leukemia
Company Healthcare Premiums Jump 12% Year‑over‑year
Just saw that our healthcare premiums we're paying as a company will increase by 12.09% YOY...
FDA's Future: New CBER Chief & Rare Disease Flexibility
On this week’s pod, we chatted with @docrodwong about the FDA, the next CBER chief and regulatory flexibility for rare diseases https://t.co/f6L7gwcNsr via @statnews
Oracle Health Powers AtlantiCare’s Vision 2030 Connected System
From unified data platforms to AI-enabled workflows, the @OracleHealth team is proud to support @AtlantiCareNJ's VISION 2030 strategy to deliver a fully connected health system. https://t.co/U0He8fVkAk
Trump Admin Boosts Medicare Advantage Bonuses, Adds $18.6B Cost
NEW: Trump admin is making it easier for Medicare Advantage plans to grab bonus $$ from star ratings. It'll cost taxpayers $18.6B over the next decade (more than the $13.2B originally expected). Will MA plans continue to cry poor? https://t.co/LPJsvb1Kck
HealthCare.gov Fix Was Planned, Not Improvised
I’ve heard people say the HealthCare gov rescue in 2013 was improvised. I was there. I watched it happen. It wasn't improvised at all.
Health Care Cuts, SCOTUS Ruling, MAHA Politics Discussed
On this week's #WTHealth podcast: R's eye more health care cuts; SCOTUS nixes ban on conversion therapy; and the politics of MAHA. W/@AliceOllstein, @SandhyaWrites, and @jessiehellmann https://t.co/SGdrcqe1nr
Small Pharma Must Strike Pricing Deal in 180 Days
New: Small pharma companies are in talks with the White House to sign drug pricing deals of their own. Small companies will have to cut a deal in the next 180 days to fully avoid tariffs on branded drugs. https://t.co/XFalvi3i3D